Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2025-12-25 @ 4:25 AM
NCT ID:
NCT00189020
Eligibility Criteria:
Inclusion Criteria:
* Newborn infants eligible for participation in the national infant vaccination program in the Netherlands
Exclusion Criteria:
exclusion from the national vaccination program because of the presence of
* a medical condition requiring treatment that can interfere with the effect of vaccinations
* known or suspected allergy to components of the pneumococcal conjugate vaccine
* known or suspected immunodeficiency disease
* previous treatment with plasma or immunoglobulins
* previous vaccinations other than hepatitis B vaccinations
* coagulation disorders
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
2 Months
Maximum Age:
3 Months
Study:
NCT00189020
Study Brief:
Protocol Section:
NCT00189020